Vyas Soumil J, Puri Yogesh S, John Biku J, Yu Dominic, Watkins Jennifer, Imber Charles, Fusai Guiseppe, Arjun Shankar, Sharma Dinesh, Davidson Brian R, Malago Massimo, Rahman Sakhawat
Division of HPB and Liver Transplant Surgery, Royal Free Hospital and Medical School, London, NW3 2QG, UK.
J Cancer Res Ther. 2016 Jan-Mar;12(1):417-21. doi: 10.4103/0973-1482.171358.
Tumors within the pancreatic head show a variable density and enhancement on computerized tomography (CT). The relationship between the radiological appearance of pancreatic adenocarcinoma on CT and survival remains unclear. The aim of this study was to evaluate the relationship between the tumor density on CT and survival. We also evaluated the correlation between lymph node (LN) size and overall survival in patients undergoing pancreaticoduodenectomy for head of pancreas adenocarcinoma.
Case records of patients undergoing pancreaticoduodenectomy for the adenocarcinoma of pancreas head, between 2005 and 2009, were evaluated. CT was interpreted to document tumor density - Hounsfield unit (HU) and LN size of enlarged LNs. Histology was analyzed to review tumor differentiation and LN status. Survival was correlated with LN size and tumor density (HU).
Increasing tumor density was significantly associated with an adverse outcome (P = 0.042, hazard ratio [HR] 1.034, 1.002-1.067 95% confidence interval [95% CI]). Patients with well-differentiated tumors had significantly lower tumor density as compared to moderately differentiated tumors (39.00 ± 26.00 vs. 71.31 ± 21.03 HU, P = 0.005). LN size more than 1 cm irrespective of LN status strongly correlated with the survival and was found to be an important prognostic factor (19.37 ± 2.71 months vs. 27.44 ± 2.74 months; P = 0.025; HR 2.70; 1.09-6.68 95% CI).
Increasing pancreatic tumor density and the lymph nodal size of more than 1 cm are strong predictors of unfavorable overall survival for resectable adenocarcinoma of the pancreatic head. Further studies are required to identify the value of these proposed prognostic factors.
胰头肿瘤在计算机断层扫描(CT)上表现出密度和强化的差异。CT上胰腺腺癌的放射学表现与生存率之间的关系仍不清楚。本研究的目的是评估CT上肿瘤密度与生存率之间的关系。我们还评估了接受胰头腺癌胰十二指肠切除术患者的淋巴结(LN)大小与总生存率之间的相关性。
评估2005年至2009年间接受胰头腺癌胰十二指肠切除术患者的病例记录。解读CT以记录肿瘤密度——亨氏单位(HU)和肿大淋巴结的LN大小。分析组织学以评估肿瘤分化和LN状态。将生存率与LN大小和肿瘤密度(HU)相关联。
肿瘤密度增加与不良预后显著相关(P = 0.042,风险比[HR] 1.034,95%置信区间[95% CI]为1.002 - 1.067)。与中度分化肿瘤相比,高分化肿瘤患者的肿瘤密度显著更低(39.00 ± 26.00 vs. 71.31 ± 21.03 HU,P = 0.005)。无论LN状态如何,LN大小超过1 cm与生存率密切相关,并且被发现是一个重要的预后因素(19.37 ± 2.71个月 vs. 27.44 ± 2.74个月;P = 0.025;HR 2.70;95% CI为1.09 - 6.68)。
胰头可切除腺癌患者中,胰腺肿瘤密度增加和LN大小超过1 cm是总体生存率不佳的有力预测指标。需要进一步研究以确定这些提出的预后因素的价值。